Whither the Hippocampus? FDG-PET Hippocampal Hypometabolism in Alzheimer Disease Revisited

References

1. 1.↵
   1. Nestor PJ,
   2. Scheltens P,
   3. Hodges JR

   . Advances in the early detection of Alzheimer's disease. Nat Med 2004;10:S34–41

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Mevel K,
   2. Desgranges B,
   3. Baron JC,
   4. et al

   . Detecting hippocampal hypometabolism in mild cognitive impairment using automatic voxel-based approaches. Neuroimage 2007;37:18–25

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Mosconi L,
   2. Tsui WH,
   3. De Santi S,
   4. et al

   . Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 2005;64:1860–67

   Abstract/FREE Full Text
4. 4.↵
   1. De Santi S,
   2. de Leon MJ,
   3. Rusinek H,
   4. et al

   . Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 2001;22:529–39

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Ishii K,
   2. Sasaki M,
   3. Yamaji S,
   4. et al

   . Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease. Dement Geriatr Cogn Disord 1998;9:317–22

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Kawachi T,
   2. Ishii K,
   3. Sakamoto S,
   4. et al

   . Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease. Eur J Nucl Med Mol Imaging 2006;33:801–09

   CrossRefPubMedWeb of Science
7. 7.↵
   1. de Leon MJ,
   2. McRae T,
   3. Rusinek H,
   4. et al

   . Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J Clin Endocrinol Metab 1997;82:3251–59

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Ouchi Y,
   2. Nobezawa S,
   3. Okada H,
   4. et al

   . Altered glucose metabolism in the hippocampal head in memory impairment. Neurology 1998;51:136–42

   Abstract/FREE Full Text
9. 9.↵
   1. de Leon MJ,
   2. Convit A,
   3. Wolf OT,
   4. et al

   . Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci USA 2001;98:10966–71

   Abstract/FREE Full Text
10. 10.↵
    1. Nestor PJ,
    2. Fryer TD,
    3. Smielewski P,
    4. et al

    . Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol 2003;54:343–51

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Matsuda H,
    2. Kanetaka H,
    3. Ohnishi T,
    4. et al

    . Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction. Eur J Nucl Med Mol Imaging 2002;29:1502–05

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Mosconi L,
    2. Sorbi S,
    3. de Leon MJ,
    4. et al

    . Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 2006;47:1778–86

    Abstract/FREE Full Text
13. 13.↵
    1. Ashburner J,
    2. Friston KJ

    . Voxel-based morphometry–the methods. Neuroimage 2000;11:805–21

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Friston KJ,
    2. Ashburner J,
    3. Poline J,
    4. et al

    . Spatial registration and normalization of images. Hum Brain Mapp 1995;2:165–89
15. 15.↵
    1. Friston KJ,
    2. Frith CD,
    3. Liddle PF,
    4. et al

    . Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991;11:690–99

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Friston KJ,
    2. Passingham RE,
    3. Nutt JG,
    4. et al

    . Localisation in PET images: direct fitting of the intercommissural (AC-PC) line. J Cereb Blood Flow Metab 1989;9:690–95

    PubMedWeb of Science
17. 17.↵
    1. Minoshima S,
    2. Frey KA,
    3. Koeppe RA,
    4. et al

    . A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG-PET. J Nucl Med 1995;36:1238–48

    Abstract/FREE Full Text
18. 18.↵
    1. Mueller SG,
    2. Weiner MW,
    3. Thal LJ,
    4. et al

    . The Alzheimer's Disease Neuroimaging Initiative. Neuroimaging Clin N Am 2005;15:869–77, xi-xii

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Jagust WJ,
    2. Bandy D,
    3. Chen K,
    4. et al

    . The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement 2010;6:221–29

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Landau SM,
    2. Harvey D,
    3. Madison CM,
    4. et al

    . Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 2009;32:1207–18

    PubMed
21. 21.↵
    1. Avants BB,
    2. Epstein CL,
    3. Grossman M,
    4. et al

    . Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal 2008;12:26–41

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Klein A,
    2. Andersson J,
    3. Ardekani BA,
    4. et al

    . Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 2009;46:786–802

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Avants B,
    2. Gee JC

    . Geodesic estimation for large deformation anatomical shape averaging and interpolation. Neuroimage 2004;23:S139–50

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Tzourio-Mazoyer N,
    2. Landeau B,
    3. Papathanassiou D,
    4. et al

    . Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Maldjian JA,
    2. Laurienti PJ,
    3. Kraft RA,
    4. et al

    . An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003;19:1233–39

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Hochberg MC,
    2. Kasper J,
    3. Williamson J,
    4. et al

    . The contribution of osteoarthritis to disability: preliminary data from the Women's Health and Aging Study. J Rheumatol Suppl 1995;43:16–18

    PubMed
27. 27.↵
    1. Benjamini Y,
    2. Drai D,
    3. Elmer G,
    4. et al

    . Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279–84

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Benjamini Y,
    2. Hochberg Y

    . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc 1995;57:289–300
29. 29.↵
    1. Yekutieli Y,
    2. Hochberg Y

    . Resampling-based false discovery rate controlling multiple test procedures for correlated test statistics. J Statist Plann Inference 1999;82:171–96

    CrossRef
30. 30.↵
    1. Dukart J,
    2. Mueller K,
    3. Horstmann A,
    4. et al

    . Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage 2010;49:1490–95

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Yakushev I,
    2. Hammers A,
    3. Fellgiebel A,
    4. et al

    . SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 2009;44:43–50

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Meltzer CC,
    2. Leal JP,
    3. Mayberg HS,
    4. et al

    . Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr 1990;14:561–70

    PubMedWeb of Science
33. 33.↵
    1. Müller-Gärtner HW,
    2. Links JM,
    3. Prince JL,
    4. et al

    . Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab 1992;12:571–83

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Casanova R,
    2. Srikanth R,
    3. Baer A,
    4. et al

    . Biological parametric mapping: A statistical toolbox for multimodality brain image analysis. Neuroimage 2007;34:137–43

    CrossRefPubMedWeb of Science